AngioDynamics (ANGO) stock price, revenue, and financials

AngioDynamics market cap is $1.1 b, and annual revenue was $291.01 m in FY 2021

$1.1 B

ANGO Mkt cap, 31-Dec-2021

$291 M

AngioDynamics Revenue FY, 2021
AngioDynamics Gross profit (FY, 2021)156.8 M
AngioDynamics Gross profit margin (FY, 2021), %53.9%
AngioDynamics Net income (FY, 2021)-31.5 M
AngioDynamics EBIT (FY, 2021)-35.3 M
AngioDynamics Cash, 31-May-202148.2 M
AngioDynamics EV1.1 B
Get notified regarding key financial metrics and revenue changes at AngioDynamicsLearn more
Banner background

AngioDynamics Revenue

AngioDynamics revenue was $291.01 m in FY, 2021

Embed Graph

AngioDynamics Revenue Breakdown

Embed Graph

AngioDynamics revenue breakdown by business segment: 21.6% from Oncology/Surgery, 35.7% from Vascular Access and 42.7% from Vascular Interventions and Therapies

AngioDynamics revenue breakdown by geographic segment: 78.7% from United States and 21.3% from International

AngioDynamics Income Statement

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

344.3m270.6m264.2m291.0m

Revenue growth, %

(2%)(21%)(2%)

Cost of goods sold

167.4m114.6m113.9m134.2m

Gross profit

176.9m156.0m150.3m156.8m

Gross profit Margin, %

51%58%57%54%

Sales and marketing expense

77.3m76.8m78.6m81.3m

R&D expense

25.5m28.3m29.7m36.4m

General and administrative expense

31.3m34.9m37.9m35.9m

Operating expense total

166.3m165.4m317.4m192.1m

Depreciation and amortization

16.6m17.1m18.1m

EBIT

10.6m(9.4m)(167.1m)(35.3m)

EBIT margin, %

3%(3%)(63%)(12%)

Interest expense

3.1m5.1m907.0k861.0k

Pre tax profit

7.5m(14.7m)(168.1m)(36.1m)

Income tax expense

(8.9m)(3.6m)(1.3m)(4.5m)

Net Income

16.3m61.3m(166.8m)(31.5m)

EPS

0.41.6(4.4)

AngioDynamics Balance Sheet

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Cash

74.1m227.6m54.4m48.2m

Accounts Receivable

39.4m43.6m31.3m35.4m

Prepaid Expenses

4.3m4.0m7.3m8.7m

Inventories

48.9m40.1m59.9m48.6m

Current Assets

168.0m315.3m152.9m140.9m

PP&E

42.5m24.3m28.3m37.1m

Goodwill

361.3m347.7m200.5m201.3m

Total Assets

705.5m836.4m594.2m561.4m

Accounts Payable

15.8m22.8m19.1m19.6m

Short-term debt

5.0m7.5m2.4m

Current Liabilities

57.3m73.3m51.4m57.6m

Long-term debt

86.6m124.4m40.0m7.3m

Total Debt

91.6m131.9m40.0m9.7m

Total Liabilities

162.9m221.6m139.3m122.0m

Common Stock

370.0k372.0k374.0k377.0k

Preferred Stock

Additional Paid-in Capital

543.8m555.0m561.9m573.5m

Retained Earnings

5.1m66.5m(100.3m)(131.9m)

Total Equity

542.6m614.8m454.9m439.5m

Debt to Equity Ratio

0.2 x0.2 x0.1 x

Debt to Assets Ratio

0.1 x0.2 x0.1 x

Financial Leverage

1.3 x1.4 x1.3 x1.3 x

AngioDynamics Cash Flow

Annual

USDFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

16.3m61.3m(166.8m)(31.5m)

Depreciation and Amortization

23.2m25.9m23.8m25.9m

Accounts Receivable

5.0m(3.2m)11.9m(4.2m)

Inventories

5.7m(1.4m)(18.8m)11.5m

Accounts Payable

(7.1m)5.2m(15.5m)4.9m

Cash From Operating Activities

41.3m37.4m(14.6m)24.1m

Purchases of PP&E

(2.4m)(3.1m)(7.2m)(5.2m)

Cash From Investing Activities

(3.7m)82.6m(63.3m)(13.7m)

Long-term Borrowings

(5.0m)(15.0m)(132.5m)(20.0m)

Cash From Financing Activities

(11.6m)33.9m(95.2m)(17.0m)

Net Change in Cash

26.6m153.5m(173.2m)(6.3m)

Interest Paid

3.2m5.1m413.0k731.0k

Income Taxes Paid

36.0k426.0k682.0k313.0k

AngioDynamics Ratios

USDFY, 2018

Revenue/Employee

300.7k

Debt/Equity

0.2 x

Debt/Assets

0.1 x

Financial Leverage

1.3 x

AngioDynamics Operating Metrics

FY, 2017FY, 2018FY, 2019FY, 2020

Manufacturing Facilities

4422

Manufacturing Facilities, sq. ft.

385.5 k385.5 k318 k317.4 k

Research and Development Centers

1111

Sales Offices

1121

Selling Space, sq. ft.

10.1 k8.1 k12.1 k8.1 k

AngioDynamics Employee Rating

3.6102 votes
Culture & Values
2.7
Work/Life Balance
3.2
Senior Management
2.7
Salary & Benefits
3.2
Career Opportunities
3
Source